Perjeta (Pertuzumab) Injection - 420mg Single-Use Vial for Intravenous Infusion

Perjeta (Pertuzumab) Injection - 420mg Single-Use Vial for Intravenous Infusion

<< >>
Usage conditions apply
Description (Brief)
(From box) Dilute prior to use; for intravenous infusion only; single-use vial; discard unused portion
(From insert)
PERJETA is a HER2/neu receptor antagonist indicated in combination with trastuzumab and docetaxel for the treatment of patients with HER2-positive metastatic breast cancer who have not received prior anti-HER2 therapy or chemotherapy for metastatic disease.
Currently not on view
Object Name
date made
ca 2013
product expiration date
Genentech, Inc.
place made
United States: California, South San Francisco
Physical Description
plastic (overall material)
glass (overall material)
metal (overall material)
cardboard (overall material)
pertuzumab, 420mg/14 mL (overall ingredient)
overall: 1 3/4 in x 2 3/4 in x 3 1/8 in; 4.445 cm x 6.985 cm x 7.9375 cm
overall: 3 in x 2 1/8 in x 2 1/8 in; 7.62 cm x 5.3975 cm x 5.3975 cm
ID Number
catalog number
accession number
Credit Line
Gift of Genentech, Inc.
Women's Health
See more items in
Medicine and Science: Medicine
Health & Medicine
The Antibody Initiative
Antibody Initiative: Monoclonal Antibodies
Data Source
National Museum of American History
Nominate this object for photography.   

Our collection database is a work in progress. We may update this record based on further research and review. Learn more about our approach to sharing our collection online.

If you would like to know how you can use content on this page, see the Smithsonian's Terms of Use. If you need to request an image for publication or other use, please visit Rights and Reproductions.


Add a comment about this object